SCHEMBL31455299

SCHEMBL31455299

Cc1cc([N+](=O)[O-])c(Nc2ccc(C3CN(C(=O)OC(C)(C)C)C3)cc2)nc1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.40
NAMPT P43490 1/20 0.38
JAK3 P52333 5/20 0.38
JAK2 O60674 4/20 0.38
PTK2 Q05397 3/20 0.38
TYMS P04818 1/20 0.38
IGF1R P08069 1/20 0.38
CKS1B P61024 2/20 0.37
SKP1 P63208 2/20 0.37
SKP2 Q13309 2/20 0.37
LCK P06239 1/20 0.36
BTK Q06187 1/20 0.36
PRKCQ Q04759 1/20 0.36
USP30 Q70CQ3 2/20 0.36
BUB1 O43683 1/20 0.36
TP53 P04637 1/20 0.36
RORC P51449 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
AURKA O14965 1/20 0.36
GSK3A P49840 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455508 0.88 MEN1 (0.39) SLC34A1NAMPTJAK3IGF1RLCK
SCHEMBL31455018 0.86 SLC34A1 (0.42) SLC34A1NAMPTJAK3JAK2PTK2
SCHEMBL31420326 0.85 NAMPT (0.40) NAMPTJAK3JAK2PTK2LCK
SCHEMBL31455504 0.80 MKNK1 (0.40) NAMPTJAK3JAK2PTK2IGF1R
SCHEMBL31455102 0.79 NAMPT (0.45) NAMPTJAK3JAK2PTK2IGF1R
SCHEMBL31455378 0.79 HPGDS (0.44) NAMPTJAK3JAK2PTK2LCK
SCHEMBL31455277 0.79 PRKCQ (0.37) SLC34A1NAMPTPRKCQUSP30TP53
SCHEMBL31454988 0.78 MAPK1 (0.43) SLC34A1JAK3LCKBTK
SCHEMBL31420375 0.77 NAMPT (0.51) NAMPTJAK3JAK2PTK2IGF1R
SCHEMBL31455683 0.77 JAK2 (0.46) SLC34A1JAK3JAK2PTK2LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059577-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed